Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ad5.SSTR/TK.RGD/ganciclovir active in phase I trial in gynecologic cancer

May 21, 2010

Hawthorn acquires license to anticancer antibodies from University of Pittsburgh

May 21, 2010

Novel Pot1 inhibitors claimed by French researchers

May 21, 2010

Health Canada grants Centocor marketing authorization for Yondelis in ovarian cancer

May 20, 2010

Oncolytics Biotech to begin phase I ReoT3D trial in colorectal cancer

May 20, 2010

JAK2 inhibitor TG-AZ1 sensitizes lung cancer cells to radiation

May 20, 2010

Myriad's candidate anticancer therapeutics inhibit Nampt

May 20, 2010

Promising preclinical profile of MEK kinase inhibitor TAK-733

May 20, 2010

FDA grants orphan drug status to Allos' pralatrexate for bladder cancer

May 19, 2010

EMA issues positive opinion for orphan status of AEZS-108 in ovarian cancer

May 19, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...